This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
Menu

Eran Benjamin, Ph.D.
Global Director, QC AD at PolyPeptide Group
Speaker

Agenda Sessions

  • Diastereomer control strategy - Teriparatide Case study

    On Demand - For Members
    View Session

At this event

Prev
Next
Cindy Berman, PhD
Toxicology Consultant
Consultant

See Eran at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub